Compounds > arsenic trioxide
Page last updated: 2024-08-21

arsenic trioxide and Carcinoma, Transitional Cell

arsenic trioxide has been researched along with Carcinoma, Transitional Cell in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dalley, CD; Ezaydi, Y; Goepel, JR; Kirkbride, P; Krishna, R; Smith, DJ; Snowden, JA; Sorour, Y1
Cao, L; Dunlevy, JR; Garrett, SH; Sens, DA; Sens, MA; Somji, S; Zheng, Y; Zhou, XD1
Chen, J; Guan, JY; Hour, TC; Huang, CY; Lu, SH; Pu, YS2
Low-Beer, TS; Robertson, DA1

Other Studies

5 other study(ies) available for arsenic trioxide and Carcinoma, Transitional Cell

ArticleYear
Histopathological response of transitional cell carcinoma to arsenic trioxide during the treatment of concurrently diagnosed acute promyelocytic leukaemia.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2008, Volume: 20, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Transitional Cell; Female; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasms, Multiple Primary; Oxides; Remission Induction; Tretinoin; Urinary Bladder Neoplasms

2008
Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer.
    Journal of applied toxicology : JAT, 2010, Volume: 30, Issue:5

    Topics: Animals; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Carcinogens; Carcinoma, Transitional Cell; Cell Line, Transformed; Cell Line, Tumor; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Keratin-6; Mice; Mice, Nude; Neoplasm Transplantation; Oxides; Urinary Bladder Neoplasms; Urothelium

2010
Cytotoxicity of arsenic trioxide to transitional carcinoma cells.
    Urology, 2002, Volume: 60, Issue:2

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Carcinoma, Transitional Cell; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glutathione; Humans; Oxides; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2002
Long term consequences of arsenical treatment for multiple sclerosis.
    British medical journal (Clinical research ed.), 1983, Feb-19, Volume: 286, Issue:6365

    Topics: Adult; Arsenic; Arsenic Trioxide; Arsenicals; Carcinoma, Transitional Cell; Humans; Hypertension, Portal; Male; Multiple Sclerosis; Oxides; Urinary Bladder Neoplasms

1983
Arsenic trioxide as a novel anticancer agent against human transitional carcinoma--characterizing its apoptotic pathway.
    Anti-cancer drugs, 2002, Volume: 13, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Carcinoma, Transitional Cell; Caspase 3; Caspases; Cisplatin; DNA, Neoplasm; Drug Resistance, Neoplasm; Enzyme Activation; G1 Phase; Humans; Membrane Potentials; Mitochondria; Oxides; Reactive Oxygen Species; Signal Transduction; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2002